NOLPAZA CONTROL medicine for heartburn 20mg pantoprazole 14 pcs

Nolpaza control 20mg 14 tablets

EAN: 5909990997268

Nolpaza control, 20 mg, enteric tablets - eliminates heartburn, reducing the amount of acid in the stomach, 14 pcs.

Nolpaza control - a drug intended for adults, used in the short-term treatment of the symptoms of gastroesophageal reflux disease. The backflow of acid from the stomach into the esophagus can lead to inflammation, which can cause pain. It may also cause a painful burning sensation in the chest that extends to the throat and a sour taste in the mouth. Nolpaza Control can relieve symptoms associated with reflux disease after the first day of use, but remember that this medicine is not intended to immediately relieve symptoms. The package contains 14 pieces.

Composition:

The active substance of the drug is pantoprazole (Pantoprazolum)

One gastro-resistant tablet contains 20 mg pantoprazole

Excipients: in the tablet core: mannitol, crospovidone (type B), anhydrous sodium carbonate, sorbitol, calcium stearate and in the tablet coating: hypromellose, povidone (K25), titanium dioxide (E 171) , iron oxide, yellow (E 172), propylene glycol, macrogol 6000, talc and methacrylic acid and ethyl acrylate copolymer (1:1) containing: sodium lauryl sulfate, polysorbate 80.Indications: p>

Nolpaza control is used for the short-term treatment of symptoms of gastroesophageal reflux disease (such as heartburn, acid regurgitation) in adults.

Properties: p>

Pantoprazole, the active substance of Nolpaza control, blocks the enzyme that produces stomach acid, which reduces the amount of acid in the stomach.

Dosage:

This medicine Always use exactly as described in the package leaflet or as directed by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist.

• The recommended dose is 1 tablet a day. The medicine should be taken for at least 2-3 consecutive days.
• You should stop taking Nolpaza control after the symptoms have completely disappeared. It is possible to improve the symptoms of acid reflux and heartburn after just one day of taking Nolpaza control, but remember that this medicine is not intended to immediately relieve symptoms.
• Consult your doctor if your symptoms will not go away after using this medicine for a full 2 ​​weeks. Do not take Nolpaza control for longer than 4 weeks without consulting your doctor.
• Take the tablets before a meal, at the same time every day.
• Swallow the tablets whole, do not crush them. and do not divide with plenty of water.

Use with other medicines:

Tell your doctor or pharmacist about all the medicines you are currently taking or recently, as well as information about any medicines you plan to take, including those obtained without a prescription.

Nolpaza control may interact with medicines such as:

• HIV protease inhibitors;
• ketoconazole;
• warfarin and phenprocoumon;
• methotrexate. ul>

Nolpaza control can be used if necessary with antacids (e.g. magaldrate, alginic acid, sodium bicarbonate, aluminum hydroxide, magnesium carbonate, or a combination of these).

Nolpaza should not be used control together with medicines that reduce the amount of acid produced in the stomach, such as omeprazole, lansoprazole, rabeprazole, ranitidine, famotidine.

Contraindications: When not to use Nolpaza control:

• If you are allergic (hypersensitive) to pantoprazole or any of the other ingredients of the medicine
• If you are taking a medicine containing atazanavir or nelfinavir (to treat HIV infection). li>

Side effects:

Like all medicines, this medicine can cause side effects, although not everyone gets them.

Tell your doctor or contact your nearest hospital emergency department immediately if any of the following serious side effects occur. At the same time, stop taking this medicine and take this leaflet and/or tablets with you.

Severe allergic reactions (rare (may affect up to 1 in 1,000 people treated)): Hypersensitivity reactions, anaphylactic reactions, anaphylactic shock, angioedema.

Severe skin reactions (frequency not known (frequency cannot be estimated from the available data)): rash with swelling, blisters or peeling of the skin, patches of peeling of the skin rying, bleeding around the eyes, nose, mouth or genitals and rapid deterioration of the general condition. Rash after exposure to the sun.

Other serious reactions (frequency unknown): inflammation of the skin and whites of the eyes, kidney problems resulting in painful urination, lower back pain. accompanied by fever.

Other side effects include:

Common (may affect up to 1 in 10 people treated): benign stomach polyps

Uncommon ( may occur in 1 in 100 treated patients): headache, dizziness, diarrhea, nausea, vomiting, flatulence and flatulence, constipation, dry mouth; abdominal pain and discomfort, skin rash or hives, itchy skin, weakness, exhaustion or malaise, sleep disturbances; increased liver enzymes in a blood test, fracture of the hip, wrist or spine.

Rare (may affect up to 1 in 1,000 people treated): disturbance or complete loss of sense of taste; visual disturbances such as blurred vision; joint pain muscle pain weight changes; increased body temperature; swelling of the limbs; depression; increased concentration of bilirubin and lipids in the blood; breast enlargement in men; high fever and a sudden decrease in the number of circulating white blood cells.

Very rare (may affect up to 1 in 10,000 people treated): disorientation, decrease in the number of platelets, decrease in the number of white blood cells, abnormal decrease numbers of red and white blood cells, as well as platelets (seen in blood tests).

Frequency not known (frequency cannot be estimated from the available data): hallucinations; confusion, decreased sodium levels in the blood, decreased magnesium levels in the blood, rash which may result in joint pain.

Warnings:

Please consult with your doctor if you:

• have been treated for heartburn or indigestion for 4 or more weeks;
• are over 55 years old and take over-the-counter indigestion medicines every day;
• is over 55 years old and has noticed new disturbing symptoms or the nature of the existing symptoms of reflux disease has changed;
• has had a stomach ulcer or has undergone stomach surgery;
• has liver problems or jaundice;
• is under constant medical care due to other serious ailments or diseases
• will have an endoscopic examination or urease test;
• if you have ever had a skin reaction to a similar medicine;
• if you are due to have a specific blood test (chromogranin A);
• if you are taking HIV protease inhibitors.

Long-term use of Nolpaza control may be associated with:

• limited absorption of vitamin B12 and vitamin B12 deficiency;
• fractures of the hip bone, wrist bone or spine;
• decrease in the concentration of magnesium in the blood. Low magnesium levels can also lead to decreased potassium and calcium levels in the blood.